-
Innovation Ranking
NewInnovation Ranking – Lowe’s Companies Inc
Lowe's Companies Inc (Lowe’s) is a home improvement products retailer. The company’s product portfolio includes kitchen appliances, building materials, tools and hardware, and lawn and garden. It also offers rough plumbing and electrical, seasonal and outdoor living, paint, flooring, millwork and outdoor power equipment. Lowe’s offers a variety of services for both interior and exterior projects, including installed sales, protection plans and repair services. It merchandises products through retail stores, online platforms, on-site locations, and contact centres. The company also...
-
Product Insights
NewLikelihood of Approval Analysis for Low-Grade Glioma
Overview How likely is it that the drugs in Low-Grade Glioma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Low-Grade Glioma Overview Low-grade gliomas are benign grade 1 and grade 2...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Everolimus in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Everolimus in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Everolimus in Low-Grade Glioma Drug Details: Everolimus (Afinitor, Votubia, RAD001) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Erdafitinib in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Erdafitinib in Low-Grade Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Erdafitinib in Low-Grade Glioma Drug Details: Erdafitinib (Balversa, Erfandel) is an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Mirdametinib in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mirdametinib in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mirdametinib in Low-Grade Glioma Drug Details: mirdametinib (PD-0325901) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ulixertinib in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ulixertinib in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulixertinib in Low-Grade Glioma Drug Details: Ulixertinib (BVD-523) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plixorafenib in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plixorafenib in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plixorafenib in Low-Grade Glioma Drug Details: FORE-8394 (PLX-8394) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Selumetinib Sulfate in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selumetinib Sulfate in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selumetinib Sulfate in Low-Grade Glioma Drug Details: Selumetinib sulfate (Koselugo /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lidocaine Hydrochloride in Low Back Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lidocaine Hydrochloride in Low Back Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lidocaine Hydrochloride in Low Back Pain Drug Details: Lidocaine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-701 in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-701 in Low-Grade Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-701 in Low-Grade Glioma Drug Details: SL-701 is under development for...